GRUBER JAMES R. (Chief Financial Officer) sold 16.9% of their position (41.71K shares) of ETON PHARMACEUTICALS, INC. on the open market
Open‑market sale worth $673.7K — a significant reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 8/20/2025ACC: 0001437749-25-027464
Officer· Chief Financial Officer
Since Apr 2022
-41.71K
Net shares
Net seller
$673.7K
Total sold
2
Open market trades
0B · 2S
2
Total transactions
41.71K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
−39.08K
Price / share
$16.16
Trade value
$631.57K
% of position
16.0%
8/19/2025
244.38K→205.30K
Common Stock
Direct
Shares
−2.63K
Price / share
$16.02
Trade value
$42.15K
% of position
1.3%
8/20/2025
207.38K→204.75K
Total
Net shares
−41.71K
Net value
-$673.71K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 8/19/2025 | S · Sale | −39.08K | $16.16 | $631.57K | 16.0% | 244.38K | 205.30K |
| Common Stock Direct | 8/20/2025 | S · Sale | −2.63K | $16.02 | $42.15K | 1.3% | 207.38K | 204.75K |
| Total | −41.71K | -$673.71K | ||||||
Derivative Transactions0
No derivative transactions reported